↓ Skip to main content

Dove Medical Press

Article Metrics

Anticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticles

Overview of attention for article published in International Journal of Nanomedicine, October 2011
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
111 Dimensions

Readers on

mendeley
103 Mendeley
Title
Anticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticles
Published in
International Journal of Nanomedicine, October 2011
DOI 10.2147/ijn.s25460
Pubmed ID
Authors

Zhijun Jiao, Yan Chen, Ying Wan, Haijun Zhang

Abstract

Doxorubicin has a broad spectrum of anticancer activity, but its clinical application is limited due to serious side effects. The aim of this study was to explore a novel drug delivery system based on titanium dioxide (TiO(2)) nanoparticles for its potential role in enhancing the anticancer efficacy of doxorubicin while reducing its side effects.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 103 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 2 2%
Unknown 101 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 22 21%
Student > Master 20 19%
Researcher 13 13%
Student > Bachelor 11 11%
Student > Doctoral Student 7 7%
Other 12 12%
Unknown 18 17%
Readers by discipline Count As %
Agricultural and Biological Sciences 19 18%
Pharmacology, Toxicology and Pharmaceutical Science 13 13%
Chemistry 12 12%
Materials Science 10 10%
Biochemistry, Genetics and Molecular Biology 5 5%
Other 20 19%
Unknown 24 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2013.
All research outputs
#15,268,549
of 22,705,019 outputs
Outputs from International Journal of Nanomedicine
#2,227
of 3,793 outputs
Outputs of similar age
#91,850
of 132,478 outputs
Outputs of similar age from International Journal of Nanomedicine
#40
of 51 outputs
Altmetric has tracked 22,705,019 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,793 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 132,478 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 51 others from the same source and published within six weeks on either side of this one. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.